AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc., a leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures, will spotlight a multitude of study results for the ORBERA® Gastric Balloon and OverStitch™ Endoscopic Suturing System during Digestive Disease Week 2016.
“ORBERA® and OverStitch™ are examples of two technologies that round out Apollo Endosurgery’s offerings of less invasive bariatric and gastrointestinal products, which gastroenterologists and surgeons have enthusiastically embraced,” said Todd Newton, Chief Executive Officer of Apollo Endosurgery. “Apollo is pleased to present a number of study results that continue to show how ORBERA® can have a tremendous impact on patients’ weight loss journeys as well as the advancement of minimally invasive therapies with OverStitch™.”
Over 30 clinical abstracts will be presented on OverStitch™ and ORBERA® that include statistical proof points supporting methods to improve the efficiency and effectiveness of both products, as well as research into possible future indications, specific use cases, and advanced tactical implementation methods for each product.
Ad Statistics
Times Displayed: 50213
Times Visited: 1424 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
During the conference, Digestive Disease Week will host several hands-on workshops including sessions that feature ORBERA® and OverStitch™ technologies. These sessions further Apollo’s mission to develop safe, effective and innovative solutions that have significant impact on minimally invasive bariatric and gastrointestinal therapies.
To learn more about ORBERA® and OverStitch™, please visit Apollo Endosurgery at booth #827 during the conference.
About OverStitch™
The OverStitch™ Endoscopic Suturing System enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope. This new technology enables a secure approximation of tissue endoscopically and a wide range of less invasive solutions for patients. OverStitch™ offers solutions for defects in both the upper and lower GI tract. Additionally, physicians are leveraging endoscopic suturing for a variety of advanced bariatric procedures. For more information regarding OverStitch™, go to: apolloendo.com.
About ORBERA®
ORBERA® is an incision-less, non-surgical weight loss solution designed for adult patients suffering from obesity, who are not appropriate for or considering invasive surgery, but for whom diet and exercise or pharmaceutical interventions have not worked.
